Range Low Price High Price Comment
30 days $84.81 $100.98 Thursday, 28th Mar 2024 BPMC stock ended at $94.86. This is 0.0738% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.38% from a day low at $93.75 to a day high of $95.98.
90 days $72.25 $100.98
52 weeks $41.54 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
2021-01-22 $99.91 $101.93 $98.36 $101.36 344 204
2021-01-21 $104.22 $105.74 $99.82 $99.86 385 467
2021-01-20 $102.71 $104.43 $101.60 $104.22 286 623
2021-01-19 $101.40 $102.79 $100.34 $102.35 340 213
2021-01-15 $102.01 $103.00 $100.57 $100.99 293 698
2021-01-14 $103.98 $106.38 $101.52 $102.51 440 849
2021-01-13 $107.22 $108.44 $103.68 $103.97 358 644
2021-01-12 $109.00 $111.03 $105.99 $107.22 411 735
2021-01-11 $105.73 $108.75 $100.01 $107.00 446 119
2021-01-08 $106.85 $108.70 $104.08 $108.28 588 048
2021-01-07 $104.27 $107.26 $102.63 $106.84 539 937
2021-01-06 $101.52 $104.92 $98.83 $104.78 557 972
2021-01-05 $104.12 $107.92 $101.78 $102.23 597 435
2021-01-04 $112.15 $113.47 $102.49 $104.57 909 199
2020-12-31 $115.11 $115.47 $111.58 $112.15 377 043
2020-12-30 $117.35 $119.94 $114.79 $115.00 281 275
2020-12-29 $122.73 $123.07 $116.17 $116.67 346 904
2020-12-28 $124.54 $124.54 $119.52 $122.45 429 751
2020-12-24 $124.49 $125.61 $122.54 $123.00 83 913
2020-12-23 $124.69 $124.71 $122.59 $124.48 225 009
2020-12-22 $121.38 $124.39 $120.80 $123.72 387 667
2020-12-21 $121.99 $123.63 $118.89 $121.68 606 810
2020-12-18 $118.29 $123.97 $117.49 $123.64 2 796 995
2020-12-17 $117.40 $118.31 $115.75 $118.17 483 017
2020-12-16 $117.54 $119.50 $116.37 $117.39 446 081
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT